DOCSLIB.ORG

Toxicological Review of Benzo[A]Pyrene – Supplemental

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Toxicological Review of Benzo[A]Pyrene – Supplemental EPA/635/R-17/003Fb www.epa.gov/iris Toxicological Review of Benzo[a]pyrene [CASRN 50-32-8] Supplemental Information January 2017 Integrated Risk Information System National Center for Environmental Assessment Office of Research and Development U.S. Environmental Protection Agency Washington, DC DISCLAIMER This document has been reviewed in accordance with U.S. Environmental Protection Agency policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. ii CONTENTS APPENDIX A. CHEMICAL PROPERTIES AND EXPOSURE INFORMATION ................................................ A-1 APPENDIX B. ASSESSMENTS BY OTHER NATIONAL AND INTERNATIONAL HEALTH AGENCIES ............ B-1 APPENDIX C. LITERATURE SEARCH STRATEGY ...................................................................................... C-1 APPENDIX D. INFORMATION IN SUPPORT OF HAZARD IDENTIFICATION AND DOSE-RESPONSE ANALYSIS ......................................................................................................................... D-1 D.1. TOXICOKINETICS .................................................................................................... D-1 D.1.1. Overview .................................................................................................. D-1 D.1.2. Absorption................................................................................................ D-1 D.1.3. Distribution .............................................................................................. D-3 D.1.4. Metabolism .............................................................................................. D-4 D.1.5. Elimination ............................................................................................. D-11 D.2. PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELS ........................ D-12 D.2.1. Recommendations for the Use of PBPK Models in Toxicity Value Derivation ............................................................................................... D-15 D.3. HUMAN STUDIES ................................................................................................. D-15 D.3.1. Noncancer Endpoints ............................................................................. D-15 D.3.2. Cancer-related Endpoints ...................................................................... D-26 D.3.3. Epidemiologic Findings in Humans ........................................................ D-29 D.4. ANIMAL STUDIES ................................................................................................. D-42 D.4.1. Oral Bioassays ........................................................................................ D-42 D.4.2. Inhalation Studies .................................................................................. D-61 D.4.3. Dermal studies ....................................................................................... D-64 D.4.4. Reproductive and Developmental Toxicity Studies ............................... D-74 D.4.5. Inhalation ............................................................................................... D-90 D.5. OTHER PERTINENT TOXICITY INFORMATION ...................................................... D-94 D.5.1. Genotoxicity Information ....................................................................... D-94 D.5.2. Tumor Promotion and Progression ...................................................... D-122 D.5.3. Benzo[a]pyrene Transcriptomic Microarray Analysis .......................... D-126 iii APPENDIX E. DOSE-RESPONSE MODELING FOR THE DERIVATION OF REFERENCE VALUES FOR EFFECTS OTHER THAN CANCER AND THE DERIVATION OF CANCER RISK ESTIMATES ....................................................................................................................... E-1 E.1. NONCANCER ENDPOINTS ....................................................................................... E-1 E.1.1. Data Sets ................................................................................................... E-1 E.1.2. Dose Response Modeling for Noncancer Endpoints................................. E-3 E.1.3. Dosimetry Modeling for Estimation of Human Equivalent Concentrations for Reference Concentration (RfC) ................................ E-40 E.2. Cancer Endpoints ................................................................................................. E-43 E.2.1. Dose-Response Modeling for the Oral Slope Factor ............................... E-43 E.2.2. Dose-Response Modeling for the Inhalation Unit Risk ........................... E-90 APPENDIX F. SUMMARY OF SAB PEER REVIEW COMMENTS AND EPA’S DISPOSITION ....................... F-1 REFERENCES FOR APPENDICES .................................................................................................................. R-1 iv TABLES Table A-1. Chemical and physical properties of benzo[a]pyrene ............................................................. A-2 Table A-2. Benzo[a]pyrene concentrations in air ..................................................................................... A-4 Table A-3. Benzo[a]pyrene levels in food ................................................................................................. A-5 Table A-4. Levels of benzo[a]pyrene in soil .............................................................................................. A-7 Table B-1. Health assessments and regulatory limits by other national and international agencies ........................................................................................................................... B-1 Table C-1. Summary of detailed search strategies for benzo[a]pyrene comprehensive literature searches (Pubmed, Toxline, Toxcenter, TSCATS) ............................................................. C-1 Table C-2. Summary of detailed literature search strategies for benzo(a)pyrene cardiovascular toxicity.............................................................................................................................. C-9 Table D-1. Exposure to benzo[a]pyrene and mortality from cardiovascular diseases in a European cohort of asphalt paving workers ................................................................. D-16 Table D-2. Exposure to benzo[a]pyrene and mortality from cardiovascular diseases in a Canadian cohort of male aluminum smelter workers .................................................. D-18 Table D-3. Exposure-related effects in Chinese coke oven workers or warehouse controls exposed to benzo[a]pyrene in the workplace .............................................................. D-24 Table D-4. Exposure-related effects in Chinese coke oven workers or warehouse controls exposed to benzo[a]pyrene in the workplace, stratified by urinary metabolite levels ............................................................................................................................. D-24 Table D-5. Background information on Chinese coke oven workers or warehouse controls exposed to benzo[a]pyrene in the workplace .............................................................. D-26 Table D-6. Studies examining skin cancer risk in relation to therapeutic coal tar ................................. D-34 Table D-7. Exposure-related effects in male Wistar rats exposed to benzo[a]pyrene by gavage 5 days/week for 5 weeks ................................................................................................. D-43 Table D-8. Exposure-related effects in Wistar rats exposed to benzo[a]pyrene by gavage 5 days/week for 5 weeks ................................................................................................. D-46 Table D-9. Means ± SDa for liver and thymus weights in Wistar rats exposed to benzo[a]pyrene by gavage 5 days/week for 90 days .............................................................................. D-48 Table D-10. Incidences of exposure-related neoplasms in Wistar rats treated by gavage with benzo[a]pyrene, 5 days/week, for 104 weeks .............................................................. D-50 Table D-11. Incidences of alimentary tract tumors in Sprague-Dawley rats chronically exposed to benzo[a]pyrene in the diet or by gavage in caffeine solution ...................................... D-53 Table D-12. Incidence of nonneoplastic and neoplastic lesions in female B6C3F1 mice fed benzo[a]pyrene in the diet for up to 2 years ................................................................ D-56 Table D-13. Other oral exposure cancer bioassays in mice ................................................................... D-57 Table D-14. Tumor incidence in the respiratory tract and upper digestive tract for male Syrian golden hamsters exposed to benzo[a]pyrene via inhalation for lifetime— Thyssen et al. (1981)a .................................................................................................... D-63 Table D-15. Skin tumor incidence and time of appearance in male C57L mice dermally exposed to benzo[a]pyrene for up to 103 weeks ....................................................................... D-66 Table D-16. Skin tumor incidence and time of appearance in male SWR, C3HeB, and A/He mice dermally exposed to benzo[a]pyrene for life or until a skin tumor was detected ....... D-67 Table D-17. Tumor incidence in female Swiss mice dermally exposed to benzo[a]pyrene for up to 93 weeks ..................................................................................................................
Load more

Recommended publications
  • Molecular Analysis on the Possible Mechanism of Β-Naphthoflavone-Induced Hepatocarcinogenesis in Rats
    J Toxicol Pathol 2007; 20: 29–37 Original Molecular Analysis on the Possible Mechanism of β-Naphthoflavone-Induced Hepatocarcinogenesis in Rats Yusuke Yokouchi1, Masako Muguruma1, Mitsuyoshi Moto1, Miwa Takahashi1, Meilan Jin1, Yusuke Kenmochi1, Taichi Kohno1, Yasuaki Dewa1, and Kunitoshi Mitsumori1 1Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3–5–8 Saiwai-cho, Fuchu, Tokyo 183–8509, Japan Abstract: It has been speculated that oxidative stress is involved in the liver tumor-promoting effect of β- naphthoflavone (BNF; 5,6-benzoflavone) in rats, because of its strong induction of cytochrome P450 (CYP) 1A enzymes. In order to clarify the mechanism of liver tumor promoting effects of BNF, male F344 rats were initiated with a single intraperitoneal injection of 200 mg/kg diethylnitrosamine (DEN), and fed diet containing 2% of BNF for 6 weeks staring 2 weeks after injection. Two/third partial hepatectomy was perfomed at Week 3 after the treatment of BNF. Low-density Rat Toxicology & Drug Resistance Microarray and quantitative analyses of mRNA expressions of the selected genes using real-time reverse transcription (RT) -PCR were carried out on total RNAs extracted from the livers of F344 rats. Collected liver tissues were subjected to light microscopic examinations (hematoxylin and eosin staining), immunohistochemistries of proliferating cell nuclear antigen (PCNA), glutathione S-transferase placental form (GST-P) and CYP1A1, and Schmorl staining to identify lipofuscin. Gene expression analysis showed that 7 genes (CYP1A1, CYP1A2, CYP1B1, Gstm2 (GST mu2), Gstm3, glutathione peroxidase (Gpx)2 and NAD(P)H dehydrogenase, quinone 1(Nqo1)) were up-regulated (> 1.5 fold), and 4 genes (8-oxoguanine DNA glycosylase (Ogg1), Gpx1, peroxiredoxin (Prdx) 1 and P450 oxidoreductase (Por)) were down-regulated (< 0.67 fold) in the DEN + BNF group rats as compared with the DEN alone group.
    [Show full text]
  • Polycyclic Aromatic Hydrocarbon Migration from Creosote-Treated Railway Ties Into Ballast and Adjacent Wetlands
    United States In cooperation Department of with the Agriculture Polycyclic Aromatic United States Forest Service Department of Transportation Hydrocarbon Migration Forest Products Federal Laboratory Highway Administration From Creosote-Treated Research Paper FPL−RP−617 Railway Ties Into Ballast and Adjacent Wetlands Kenneth M. Brooks Abstract from the weathered ties at this time. No significant PAH loss was observed from ties during the second summer. A Occasionally, creosote-treated railroad ties need to be small portion of PAH appeared to move vertically down into replaced, sometimes in sensitive environments such as the ballast to approximately 60 cm. Small amounts of PAH wetlands. To help determine if this is detrimental to the may have migrated from the ballast into adjacent wetlands surrounding environment, more information is needed on during the second summer, but these amounts were not the extent and pattern of creosote, or more specifically poly- statistically significant. These results suggest that it is rea- cyclic aromatic hydrocarbon (PAH), migration from railroad sonable to expect a detectable migration of creosote-derived ties and what effects this would have on the surrounding PAH from newly treated railway ties into supporting ballast environment. This study is a report on PAH level testing during their first exposure to hot summer weather. The PAH done in a simulated wetland mesocosm. Both newly treated rapidly disappeared from the ballast during the fall and and weathered creosote-treated railroad ties were placed in winter following this initial loss. Then statistically insignifi- the simulated wetland. As a control, untreated ties were also cant vertical and horizontal migration of these PAH suggests placed in the mesocosm.
    [Show full text]
  • Safeguards Benzopyrene Contamination in Korean
    SAFEGUARDS SGS CONSUMER TESTING SERVICES FOOD NO. 187/12 NOV 2012 BENZOPYRENE CONTAMINATION IN KOREAN INSTANT NOODLE On 25 Oct 2012, Korea Food and Drug Administration (KFDA) recalled six instant noodle products from the nation’s largest ramen maker in South Korea because these products were found to be tainted with benzo(a) pyrene, which is a known carcinogen.1 Several countries, including Philippines, Thailand, Taiwan and China, have been alerted to this and as a precaution, have removed these products from their shelves. Benzo(a)pyrene belongs to the group of polycyclic aromatic hydrocarbons (PAHs). Most PAHs derive from incomplete burning of carbon containing materials such as petroleum fuels, wood, and garbage. The occurrence of PAHs in foods is mainly caused by environmental contamination (water, air and soil), food processing (direct drying and heating), and packaging materials. PAHs have been found in different food products, such as dairy products, vegetables, fruits, oil, coffee, tea, cereals, smoked meat, seafood products, ingredients for food formulation, seasoning, and instant noodles. announcement of the test results and the recall order because the levels of In June, the KFDA conducted tests on benzopyrene found in the noodle products in June were minuscule and not harmful, 30 instant noodle products sold in the South Korean agency reported. However, the KFDA issued the recall order after South Korea and found that six its commissioner Lee Hee-sung was pressed on the matter during a legislative products contained benzopyrene, with question-and-answer, the report indicated.2 one product containing the highest level of 4.7 parts per billion (µg/kg).
    [Show full text]
  • Polycyclic Aromatic Hydrocarbon Structure Index
    NIST Special Publication 922 Polycyclic Aromatic Hydrocarbon Structure Index Lane C. Sander and Stephen A. Wise Chemical Science and Technology Laboratory National Institute of Standards and Technology Gaithersburg, MD 20899-0001 December 1997 revised August 2020 U.S. Department of Commerce William M. Daley, Secretary Technology Administration Gary R. Bachula, Acting Under Secretary for Technology National Institute of Standards and Technology Raymond G. Kammer, Director Polycyclic Aromatic Hydrocarbon Structure Index Lane C. Sander and Stephen A. Wise Chemical Science and Technology Laboratory National Institute of Standards and Technology Gaithersburg, MD 20899 This tabulation is presented as an aid in the identification of the chemical structures of polycyclic aromatic hydrocarbons (PAHs). The Structure Index consists of two parts: (1) a cross index of named PAHs listed in alphabetical order, and (2) chemical structures including ring numbering, name(s), Chemical Abstract Service (CAS) Registry numbers, chemical formulas, molecular weights, and length-to-breadth ratios (L/B) and shape descriptors of PAHs listed in order of increasing molecular weight. Where possible, synonyms (including those employing alternate and/or obsolete naming conventions) have been included. Synonyms used in the Structure Index were compiled from a variety of sources including “Polynuclear Aromatic Hydrocarbons Nomenclature Guide,” by Loening, et al. [1], “Analytical Chemistry of Polycyclic Aromatic Compounds,” by Lee et al. [2], “Calculated Molecular Properties of Polycyclic Aromatic Hydrocarbons,” by Hites and Simonsick [3], “Handbook of Polycyclic Hydrocarbons,” by J. R. Dias [4], “The Ring Index,” by Patterson and Capell [5], “CAS 12th Collective Index,” [6] and “Aldrich Structure Index” [7]. In this publication the IUPAC preferred name is shown in large or bold type.
    [Show full text]
  • Estimation of Enthalpy of Bio-Oil Vapor and Heat Required For
    Edinburgh Research Explorer Estimation of Enthalpy of Bio-Oil Vapor and Heat Required for Pyrolysis of Biomass Citation for published version: Yang, H, Kudo, S, Kuo, H-P, Norinaga, K, Mori, A, Masek, O & Hayashi, J 2013, 'Estimation of Enthalpy of Bio-Oil Vapor and Heat Required for Pyrolysis of Biomass', Energy & Fuels, vol. 27, no. 5, pp. 2675-2686. https://doi.org/10.1021/ef400199z Digital Object Identifier (DOI): 10.1021/ef400199z Link: Link to publication record in Edinburgh Research Explorer Document Version: Early version, also known as pre-print Published In: Energy & Fuels General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 04. Oct. 2021 Estimation of Enthalpy of Bio-oil Vapor and Heat Required for Pyrolysis of Biomass Hua Yang,† Shinji Kudo,§ Hsiu-Po Kuo,‡ Koyo Norinaga, ξ Aska Mori, ξ Ondřej Mašek,|| and Jun-ichiro Hayashi †, ξ, §, * †Interdisciplinary Graduate School of Engineering Sciences, Kyushu University,
    [Show full text]
  • University of Groningen Drug Metabolism in Human and Rat
    University of Groningen Drug metabolism in human and rat intestine van de Kerkhof, Esther Gesina IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2007 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): van de Kerkhof, E. G. (2007). Drug metabolism in human and rat intestine: an 'in vitro' approach. s.n. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 27-09-2021 Chapter 5 Induction of drug metabolism along the rat intestinal tract EG van de Kerkhof IAM de Graaf MH de Jager GMM Groothuis In preparation Chapter 5 Abstract Induction of drug metabolizing enzymes in the intestine can result in a marked variation in the bioavailability of drugs and cause an imbalance between local toxification and detoxification.
    [Show full text]
  • Analysis of Benzopyrenes and Benzopyrene Metabolites by Fluorescence Spectroscopy Techniques
    University of Central Florida STARS Electronic Theses and Dissertations, 2004-2019 2016 Analysis of Benzopyrenes and Benzopyrene Metabolites by Fluorescence Spectroscopy Techniques Bassam Al-Farhani University of Central Florida Part of the Chemistry Commons Find similar works at: https://stars.library.ucf.edu/etd University of Central Florida Libraries http://library.ucf.edu This Doctoral Dissertation (Open Access) is brought to you for free and open access by STARS. It has been accepted for inclusion in Electronic Theses and Dissertations, 2004-2019 by an authorized administrator of STARS. For more information, please contact [email protected]. STARS Citation Al-Farhani, Bassam, "Analysis of Benzopyrenes and Benzopyrene Metabolites by Fluorescence Spectroscopy Techniques" (2016). Electronic Theses and Dissertations, 2004-2019. 5286. https://stars.library.ucf.edu/etd/5286 ANALYSIS OF BENZOPYRENES AND BENZOPYRENE METABOLITES BY FLUORESCENCE SPECTROSCOPY TECHNIQUES by BASSAM AL-FARHANI B.Sc. Alnahrain University Iraq, 2002 M.Sc. Alnahrain University Iraq, 2005 A dissertation submitted in partial fulfilment of the requirements for the degree of Doctor of Philosophy in the Department of Chemistry in the College of Sciences at the University of Central Florida Orlando, Florida Spring Term 2016 Major Professor: Andres D. Campiglia © 2016 Bassam Al-farhani ii ABSTRACT Polycyclic aromatic hydrocarbons (PAHs) are some of the most common and toxic pollutants encountered worldwide. Presently, monitoring is restricted to sixteen PAHs, but it is well understood that this list omits many toxic PAHs. Among the “forgotten” PAHs, isomers with molecular weight 302 are of particular concern due to their high toxicological properties. The chromatographic analysis of PAHs with MW 302 is challenged by similar retention times and virtually identical mass fragmentation patterns.
    [Show full text]
  • Time-Dependent Inhibition by 2,3,7,8-Tetrachlorodibenzo-P-Dioxin of Skin Tumorigenesis with Polycyclic Hydrocarbons1
    [CANCER RESEARCH 40. 1580-1587, May 1980] 0008-5472/80/0040-OOOOS02.00 Time-dependent Inhibition by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of Skin Tumorigenesis with Polycyclic Hydrocarbons1 J. DiGiovanni,2 D. L. Berry, G. L. Gleason, G. S. Kishore, and T. J. Slaga McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706 ¡J. D.. G. S K.J. and Biology Division, Oak Ridge National Laboratory. Oak Ridge. Tennessee 37830 ¡D.L B . G L G.. T. J. S.J ABSTRACT reactive intermediates that are capable of interacting covalently with cellular macromolecules (20). The interaction with DNA, a The effects of treating female mice with single topical doses target for activated PAH intermediates, has received consid of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at various times erable attention in recent years and is presently considered a before and after 7,12-dimethylbenz(a)anthracene (DMBA), critical event in the initiation of chemical carcinogenesip. Cur benzo(a)pyrene, 3-methylcholanthrene (MCA), and (±)-trans- rent evidence suggests that bay-region diol-epoxides may be 7/S,8«-dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo(a)- ultimate carcinogenic forms for some PAH (24). This is sup pyrene were studied. TCDD, at doses of 1 /ig/mouse, was ported by recent data concerning BaP and DMBA epoxides applied topically 3 days prior to, 5 min prior to, or 1 day after that produce a DMA-binding product similar to that isolated in the initiator. The application of TCDD 5 min prior to or 1 day vivo after treatment with the parent hydrocarbon (2, 11, 17, after initiation with DMBA, benzo(a)pyrene, or MCA had little 22, 33, 42, 48, 49).
    [Show full text]
  • Ambient Water Quality Criteria for Polycyclic Aromatic Hydrocarbons (Pahs)
    Ambient Water Quality Criteria For Polycyclic Aromatic Hydrocarbons (PAHs) Ministry of Environment, Lands and Parks Province of British Columbia N. K. Nagpal, Ph.D. Water Quality Branch Water Management Division February, 1993 ACKNOWLEDGEMENTS The author is indebted to the following individual and agencies for providing valuable comments during the preparation of this document. Dr. Ray Copes BC. Ministry of Health, Victoria, BC. Dr. G. R. Fox Environmental Protection Div., BC. MOELP, Victoria, BC. Mr. L. W. Pommen Water Quality Branch, BC. MOELP, Victoria, BC. Mr. R. J. Rocchini Water Quality Branch, BC. MOELP, Victoria, BC. Ms. Sherry Smith Eco-Health Branch, Conservation and Protection, Environment Canada, Hull, Quebec Mr. Scott Teed Eco-Health Branch, Conservation and Protection, Environment Canada, Hull, Quebec Ms. Bev Raymond Integrated Programs Branch, Inland Waters, Environment Canada, North Vancouver, BC. 1.0 INTRODUCTION Polycyclic aromatic hydrocarbons (PAHs) are organic compounds which are non- essential for the growth of plants, animals or humans; yet, they are ubiquitous in the environment. When present in sufficient quantity in the environment, certain PAHs are toxic and carcinogenic to plants, animals and humans. This document discusses the characteristics of PAHs and their effects on various water uses, which include drinking Ministry of Environment Water Protection and Sustainability Branch Mailing Address: Telephone: 250 387-9481 Environmental Sustainability PO Box 9362 Facsimile: 250 356-1202 and Strategic Policy Division Stn Prov Govt Website: www.gov.bc.ca/water Victoria BC V8W 9M2 water, aquatic life, wildlife, livestock watering, irrigation, recreation and aesthetics, and industrial water supplies. A significant portion of this document discusses the effects of PAHs upon aquatic life, due to its sensitivity to PAHs.
    [Show full text]
  • Role of Aryl Hydrocarbon Receptor in Central Nervous System Tumors: Biological and Therapeutic Implications (Review)
    ONCOLOGY LETTERS 21: 460, 2021 Role of aryl hydrocarbon receptor in central nervous system tumors: Biological and therapeutic implications (Review) MONTSERRAT ZARAGOZA‑OJEDA1,2, ELISA APATIGA‑VEGA1 and FRANCISCO ARENAS‑HUERTERO1 1Laboratorio de Investigación en Patología Experimental, Hospital Infantil de México Federico Gómez, Mexico City 06720; 2Posgrado en Ciencias Biológicas, Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04510, México Received January 28, 2020; Accepted January 25, 2021 DOI: 10.3892/ol.2021.12721 Abstract. Aryl hydrocarbon receptor (AHR) is a ligand‑ 6. Non‑canonical AhR pathway activated transcription factor, whose canonical pathway 7. Potential therapeutic applications of the crosstalk between mainly regulates the genes involved in xenobiotic metabolism. AhR pathway and central nervous system tumors However, it can also regulate several responses in a non‑ 8. Conclusions canonical manner, such as proliferation, differentiation, cell death and cell adhesion. AhR plays an important role in central nervous system tumors, as it can regulate several 1. Background of AhR research cellular responses via different pathways. The polymorphisms of the AHR gene have been associated with the development of The study of AhR can be discussed from two standpoints; the gliomas. In addition, the metabolism of tumor cells promotes first one reflects the reality of current times, that is, human tumor growth, particularly in tryptophan synthesis, where exposure to synthetic organic compounds and the conse‑ some metabolites, such as kynurenine, can activate the AhR quences that has on human health. During the 1970s, the pathway, triggering cell proliferation in astrocytomas, medul‑ studies of several toxicologists, biochemists and molecular loblastomas and glioblastomas.
    [Show full text]
  • Summary of Information for ABC for Polycyclic Aromatic Hydrocarbons
    Air Toxics Science Advisory Committee Summary of Information for ABC for Polycyclic Aromatic Hydrocarbons September 16, 2015 ATSAC Meeting #10 Presenter: Sue MacMillan, DEQ ATSAC lead Sue MacMillan | Oregon Department of Environmental Quality 26 Individual PAHs to Serve as Basis of ABC for Total PAHs Acenaphthene Cyclopenta(c,d)pyrene Acenaphthylene Dibenzo(a,h)anthracene Anthracene Dibenzo(a,e)pyrene Anthanthrene Dibenzo(a,h)pyrene Benzo(a)pyrene Dibenzo(a,i)pyrene Naphthalene Benz(a)anthracene Dibenzo(a,l)pyrene has separate Benzo(b)fluoranthene Fluoranthene ABC. Benzo(k)fluoranthene Fluorene Benzo( c)pyrene Indeno(1,2,3-c,d)pyrene Benzo(e)pyrene Phenanthrene Benzo(g,h,i)perylene Pyrene Benzo(j)fluoranthene 5-Methylchrysene Chrysene 6-Nitrochrysene Use of Toxic Equivalency Factors for PAHs • Benzo(a)pyrene serves as the index PAH, and has a documented toxicity value to which other PAHs are adjusted • Other PAHs adjusted using Toxic Equivalency Factors (TEFs), aka Potency Equivalency Factors (PEFs). These values are multipliers and are PAH-specific. • Once all PAH concentrations are adjusted to account for their relative toxicity as compared to BaP, the concentrations are summed • This summed concentration is then compared to the toxicity value for BaP, which is used as the ABC for total PAHs. Source of PEFs for PAHs • EPA provides a range of values of PEFs for each PAH • Original proposal suggested using upper-bound value of each PEF range as the PEF to use for adjustment of our PAHs • Average PEF value for each PAH is a better approximation of central tendency, and is consistent with the use of PEFs by other agencies • Result of using average, rather than upper-bound PEFs: slightly lower summed concentrations for adjusted PAHs, thus less apt to exceed ABC for total PAHs Documents can be provided upon request in an alternate format for individuals with disabilities or in a language other than English for people with limited English skills.
    [Show full text]
  • Table 2. Chemical Names and Alternatives, Abbreviations, and Chemical Abstracts Service Registry Numbers
    Table 2. Chemical names and alternatives, abbreviations, and Chemical Abstracts Service registry numbers. [Final list compiled according to the National Institute of Standards and Technology (NIST) Web site (http://webbook.nist.gov/chemistry/); NIST Standard Reference Database No. 69, June 2005 release, last accessed May 9, 2008. CAS, Chemical Abstracts Service. This report contains CAS Registry Numbers®, which is a Registered Trademark of the American Chemical Society. CAS recommends the verification of the CASRNs through CAS Client ServicesSM] Aliphatic hydrocarbons CAS registry number Some alternative names n-decane 124-18-5 n-undecane 1120-21-4 n-dodecane 112-40-3 n-tridecane 629-50-5 n-tetradecane 629-59-4 n-pentadecane 629-62-9 n-hexadecane 544-76-3 n-heptadecane 629-78-7 pristane 1921-70-6 n-octadecane 593-45-3 phytane 638-36-8 n-nonadecane 629-92-5 n-eicosane 112-95-8 n-Icosane n-heneicosane 629-94-7 n-Henicosane n-docosane 629-97-0 n-tricosane 638-67-5 n-tetracosane 643-31-1 n-pentacosane 629-99-2 n-hexacosane 630-01-3 n-heptacosane 593-49-7 n-octacosane 630-02-4 n-nonacosane 630-03-5 n-triacontane 638-68-6 n-hentriacontane 630-04-6 n-dotriacontane 544-85-4 n-tritriacontane 630-05-7 n-tetratriacontane 14167-59-0 Table 2. Chemical names and alternatives, abbreviations, and Chemical Abstracts Service registry numbers.—Continued [Final list compiled according to the National Institute of Standards and Technology (NIST) Web site (http://webbook.nist.gov/chemistry/); NIST Standard Reference Database No.
    [Show full text]